AMERIPRISE FINANCIAL INC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 78 filers reported holding ATHIRA PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$30,906
-31.5%
15,3000.0%0.00%
Q2 2023$45,135
+55.2%
15,300
+31.5%
0.00%
Q1 2023$29,090
-73.6%
11,636
-66.3%
0.00%
Q4 2022$110,000
+7.8%
34,547
+0.0%
0.00%
Q3 2022$102,000
-98.7%
34,542
-94.1%
0.00%
-100.0%
Q1 2022$7,892,000
+41.4%
584,550
+36.5%
0.00%0.0%
Q4 2021$5,581,000
+34.6%
428,300
-3.1%
0.00%
+100.0%
Q3 2021$4,147,000442,1200.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$31,126,0003.38%
ACUTA CAPITAL PARTNERS, LLC 400,000$7,360,0002.65%
Logos Global Management LP 1,010,812$18,599,0001.82%
S Squared Technology, LLC 181,220$3,334,0001.58%
Avidity Partners Management LP 1,677,845$30,872,0000.85%
Perceptive Advisors 3,425,916$63,037,0000.80%
RTW INVESTMENTS, LP 2,652,553$48,807,0000.76%
Sofinnova Investments, Inc. 509,168$9,369,0000.56%
HighVista Strategies LLC 32,062$590,0000.44%
DAFNA Capital Management LLC 91,531$1,684,0000.40%
View complete list of ATHIRA PHARMA INC shareholders